logo-loader
Horizon Discovery Group PLC

Horizon Dis Grp plc - Block Listing Six Monthly Return

RNS Number : 7683G
Horizon Discovery Group plc
26 July 2019
 

RNS

Horizon Discovery Group plc

Block Listing Six Monthly Return and Block Listing Application

 

26 July 2019: Horizon Discovery Group plc (LSE: HZD) ("Horizon") provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

Name of applicant:

Horizon Discovery Group plc

Name of scheme(s):

a)   Horizon Discovery Limited Enterprise Management Incentive Share Option Scheme

b)   Horizon Discovery Group plc Long Term Incentive Plan

c)   Horizon Discovery 2014 Sharesave Scheme

d)   Horizon Discovery Group plc US Employee Stock Purchase Plan

Period of return (from / to):

From: 26 January 2019

To: 25 July 2019

Number of securities admitted and date of admission

Total of 3,000,000 ordinary shares of 1p each, admission date 26 July 2017, split:

a)   1,398,000 

b)   1,392,000

c)   110,000

d)   100,000

Further 500,000 ordinary shares of 1p each, admission date 27 July 2018, split:

a) 0

b) 150,000

c) 150,000

d) 200,000

 

Balance of unallotted securities under schemes from previous return:

Total of 1,756,424 ordinary shares of 1p each, split

a) 616,750

b) 926,020

c) 98,065

d) 115,589

 

Plus: The amount by which the block scheme(s) has been increased or application has been made to increase since the date of the last return (if any increase has been applied for):

0

 

Less: Number of securities issued/allotted under scheme(s) during period:

Total of 32,432 ordinary shares of 1p each, split

a) 7,000

b) 13,127

c) 12,305

d) 0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

Total of 1,723,992 ordinary shares of 1p each, split

a) 609,750

b) 912,893

c) 85,760

d) 115,589

ENDS

For further information from Horizon Discovery Group plc, please contact:

Horizon Discovery Group plc

Terry Pizzie, Chief Executive Officer

Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Tel: +44 (0) 1223 655 580

 

Numis Securities Limited (Broker and NOMAD)

Freddie Barnfield / Tom Ballard / Duncan Monteith

Tel: +44 (0) 207 260 1000

 

Consilium Strategic Communications (Financial Media and Investor Relations)

Mary-Jane Elliott / Matthew Neal / Melissa Gardiner

Tel: +44 (0) 20 3709 5700

Email: horizon@consilium-comms.com

 

About Horizon Discovery Group plc www.horizondiscovery.com

Horizon Discovery Group plc (LSE: HZD) ("Horizon") drives the application of gene editing and gene modulation within the global life science market - supporting scientists on the path from research to therapy.

Built upon more than a decade of experience in the engineering of cell lines, Horizon offers an unmatched portfolio of tools and services to help scientists gain a greater understanding of gene function, identify genetic drivers behind human disease, deliver biotherapeutics, cellular and gene therapies for precision medicine as well as develop and validate diagnostic workflows.

Horizon's solutions enable almost any gene to be altered, or its function modulated, in human and other mammalian cell lines.

The Company's customers include many of the world's foremost academic institutes, global pharmaceutical and biotechnology companies as well as clinical diagnostic laboratories. Insight into the challenges faced by these organizations enables Horizon to focus efforts on development of innovative solutions that not only differentiate the Company's offering, but also fuel development of the next wave of precision medicines.

Horizon is headquartered in Cambridge, UK with offices in USA and Japan.  The Group is listed on the London Stock Exchange's AIM market under the ticker HZD.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRCKPDBQBKDCOB
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

Acquisition gives Horizon Discovery a 'full and complete suite of tools' to...

Chris Claxton, VP Investor Relations & Corporate Communications at Horizon Discovery Group PLC (LON:HZD), discusses with Proactive their 'transformational' acquisition of GE healthcare business Dharmacon. The US$85mln deal was announced in July and funded through cash and shares and...

on 4/9/17

3 min read